NIH Funding Opportunity: Collaborative Research in Fragile X and FMR1-Associated Conditions

NICHD is excited to announce the publication of RFA-HD-20-003: Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional).

In recognition of the rapidly evolving landscape of FMR1-associated research, NIH recently published a new Strategic Plan for Research on FMR1-Associated Conditions.  This Strategic Plan, which was developed in collaboration with many members of the Fragile X community, articulates NIH’s current research priorities, which are directed toward an overarching vision of accelerating the development of effective interventions to prevent or treat FMR1-associated conditions. Successful Fragile X Centers will be composed of multidisciplinary teams of basic, translational and clinical investigators collaborating to address complex, difficult-to-solve problems within specific research priorities identified in the Strategic Plan.

Fragile X- Primary Ovarian Insufficiency (FX-POI) Remains A Priority Area For This RFA.

Application Period March 3-April 3, 2020.

An informational webinar is planned in mid-late February for anyone potentially interested in applying under this RFA.  In the meantime, please feel free to reach out to Dr. Susan Taymans (301-496-6517 office; 301-640-6055 cell; or any of the NIH contacts listed in the RFA with any questions.
is a patient education website of ASRM.

COVID-19 updates
Advocacy Day 2020